Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(8%)
Results Posted
13%(1 trials)

Phase Distribution

Ph not_applicable
2
15%
Ph phase_4
8
62%
Ph phase_3
2
15%

Phase Distribution

0

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution12 total trials
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
8(66.7%)
N/ANon-phased studies
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(8)
Other(3)

Detailed Status

Completed8
unknown3
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (16.7%)
Phase 48 (66.7%)
N/A2 (16.7%)

Trials by Status

recruiting18%
enrolling_by_invitation18%
completed862%
unknown323%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
13